Associate Professor, Medicine, University of Washington School of Medicine
Pulmonology
Dr. Christopher H. Goss, MD
|
|
Give Review
Christopher Goss is an expert in the field of Pulmonology. Doctor Christopher H. Goss, MD has written publications. He has 84 publications published with PubMed. The lastest publication is: 'Optimising treatment of CF pulmonary exacerbation: a tough nut to crack.'
Publications
- Short-term and long-term response to Pulmonary exacerbation treatment in cystic fibrosis.
- Optimising treatment of CF Pulmonary exacerbation: a tough nut to crack.
- Country to country variation: what can be learnt from national Cystic fibrosis registries.
- It Starts at the Beginning: Effect of Particulate Matter In Utero.
- Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and Cystic fibrosis phenotype.
- The burden of influenza-associated critical illness hospitalizations*.
- Obese Patients with Idiopathic Pulmonary Fibrosis have a Higher 90-day Mortality Risk with Bilateral Lung Transplantation.
- Highly Effective Cystic Fibrosis Clinical Research Teams: Critical Success Factors.
- Prevalence of Symptoms of Depression and Anxiety in Adults With Cystic Fibrosis Based on the PHQ-9 and GAD-7 Screening Questionnaires.
- Unintended Consequences of Therapy in the Intensive Care Unit.
- The yin and yang of indoor airborne exposures to endotoxin.
- An Official American Thoracic Society Research Statement: Comparative Effectiveness Research in Pulmonary, Critical Care, and Sleep Medicine.
- Pulmonary exacerbations in CF patients with early lung disease.
- Comparative effectiveness research - what is it and how does one do it?
- Population-Based Incidence Estimates of Influenza-Associated Respiratory Failure Hospitalizations, 2003 - 2009.
- Update in Cystic fibrosis 2012.
- Nature and correlates of post-traumatic stress symptomatology in Lung transplant recipients.
- Pulmonary exacerbations as indicators of progression of lung disease in young children with CF.
- Incidence and clinical significance of elevated liver function tests in Cystic fibrosis clinical trials.
- Aztreonam for inhalation solution, challenges to drug approval and integration into CF care.
- Disparities in Access to Lung Transplantation for Cystic Fibrosis Patients by Socioeconomic Status.
- Respiratory Outbreak of Mycobacterium abscessus Subspecies massiliense in a Lung Transplant and Cystic Fibrosis Center.
- A story of success: continuous quality improvement in Cystic fibrosis care in the USA.
- Is Severe Sepsis Associated With New-Onset Atrial Fibrillation and Stroke?
- Autologous serum skin test response in Chronic spontaneous urticaria and respiratory diseases and its relationship with serum interleukin-18 level.
- Review: Staphylococcus aureus and MRSA in Cystic fibrosis.
- Risk Factors for Chronic Kidney Disease in Adults with Cystic Fibrosis.
- Comparative effectiveness research: what happened to incorporating costs of care?
- Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis.
- Genetic variation in the FAS gene and associations with acute Lung injury.
- Monitoring influenza activity in the United States: a comparison of traditional surveillance Systems with google flu trends.
- Comparison of 7-day and repeated 24-hour recall of symptoms of Cystic fibrosis.
- Predictors of influenza vaccination in the Cystic Fibrosis Foundation patient registry, 2006 through 2007.
- Out-of-hospital characteristics and care of patients with severe sepsis: a cohort study.
- Failure to recover to baseline Pulmonary function after cystic fibrosis Pulmonary exacerbation.
- Factors associated with mortality in patients with tuberculosis.
- Development of a predictive model for long-term survival after Lung transplantation and implications for the Lung allocation score.
- Effect of azithromycin on Pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
- Out-of-hospital fluid in severe sepsis: effect on early resuscitation in the emergency department.
- Influenza-associated cystic fibrosis Pulmonary exacerbations.
- Return of FEV1 after Pulmonary exacerbation in children with cystic fibrosis.
- Long-term survival after hospitalization for community-acquired and healthcare-associated Pneumonia.
- Cystic fibrosis Pulmonary guidelines: treatment of Pulmonary exacerbations.
- Patient-reported respiratory symptoms in Cystic fibrosis.
- Pulmonary function in the morbidly obese.
- Contraceptive practices in women with Cystic fibrosis.
- Changes in arterial oxygenation and self-reported oxygen use after Lung volume reduction surgery.
- Should we stop using intravenous gentamicin in patients with Cystic fibrosis?
- Experience using centralized spirometry in the phase 2 randomized, placebo-controlled, double-blind trial of denufosol in patients with mild to moderate Cystic fibrosis.
- Factors associated with severe disease in a population of Asthmatic children of Bogota, Colombia.
- Alveolar macrophage secretory products augment the response of rat Pulmonary artery endothelial cells to hypoxia and reoxygenation.
- Effect of mycophenolate mofetil on Pulmonary function in scleroderma-associated interstitial lung disease.
- Lung allocation score for Lung transplantation: impact on disease severity and survival.
- Cystic fibrosis pulmonary guidelines: Chronic medications for maintenance of lung health.
- A patient with vanishing Lung syndrome and remarkable tolerance to high altitude.
- Patient-reported outcomes in Cystic fibrosis.
- Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in Cystic fibrosis.
- Exacerbations in Cystic fibrosis. 1: Epidemiology and pathogenesis.
- Laboratory parameter profiles among patients with Cystic fibrosis.
- Respiratory adverse event profiles in Cystic fibrosis placebo subjects in short- and long-term inhaled therapy trials.
- CFTR genotype as a predictor of prognosis in Cystic fibrosis.
- Study of a novel pancreatic enzyme replacement therapy in pancreatic insufficient subjects with Cystic fibrosis.
- Hospital volume and the outcomes of mechanical ventilation.
- Clinician statements and family satisfaction with family conferences in the intensive care unit.
- Aggressive prenatal care results in successful fetal outcomes in CF women.
- Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient Cystic fibrosis patients.
- Clinical trial participants compared with nonparticipants in Cystic fibrosis.
- Disease-specific reference equations for Lung function in patients with cystic fibrosis.
- Association between Stenotrophomonas maltophilia and Lung function in cystic fibrosis.
- Update on Cystic fibrosis epidemiology.
- Early tumor necrosis factor-alpha release from the Pulmonary macrophage in lung ischemia-reperfusion injury.
- Effect of ambient air pollution on Pulmonary exacerbations and lung function in cystic fibrosis.
- Cost and incidence of social comorbidities in low-risk patients with community-acquired Pneumonia admitted to a public hospital.
- The effect of pregnancy on survival in women with Cystic fibrosis.
- Improved survival among young patients with Cystic fibrosis.
- Incidence of acute Lung injury in the United States.
- Analysis of sequential aliquots of hypertonic saline solution-induced sputum from clinically stable patients with Cystic fibrosis.
- Airway clearance in Cystic fibrosis.
- Developing cystic fibrosis Lung transplant referral criteria using predictors of 2-year mortality.
- The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan Diseases.
- Detecting Stenotrophomonas maltophilia does not reduce survival of patients with Cystic fibrosis.
- Effect of an older sibling and birth interval on the risk of childhood injury.
- Influenza Pneumonia Surveillance among Hospitalized Adults May Underestimate the Burden of Severe Influenza Disease.
Schools
UNIVERSITY OF COLORADO AT DENVER
University Of Washington Seattle
Procedures Preformed
- Bronchoscopy
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Alkalosis
- Asthma
- Atelectasis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
Drug Facts
| NPI NUMBER | 1457436289 | |
| NPPES Provider LastName | GOSS | |
| NPPES Provider FirstName | CHRISTOPHER | |
| NPPES Provider ZIPCode | 981956166 | |
| NPPES Provider State | WA | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 161.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1457436289 |
| Last Name Of The Provider | GOSS |
| First Name Of The Provider | CHRISTOPHER |
| View All |
Similar Doctors
|
|
Dr. Embra Roper, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Manika Jamwal, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Matthias K. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew M. Luks, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sina A. Gharib, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arthur E. Anderson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ajai A. Dandekar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robb W. Glenny, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Alan B. Montgomery, MD |
|
|
Dr. David H. Au, MD |
|
|
Dr. Barry J. Plant, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pradeep K. Singh, MD |